Literature DB >> 11692070

Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy.

J Neuberger1, E A Jones.   

Abstract

A woman with stage III (pre-cirrhotic) primary biliary cirrhosis was referred for liver transplantation because of intractable pruritus. Oral administration of 50 mg naltrexone precipitated a severe opioid withdrawal-like reaction. Subsequently, when oral naltrexone therapy was reintroduced following a cautious infusion of naloxone, no reaction occurred and the pruritus resolved completely. Liver transplantation should not be considered for apparently intractable pruritus of cholestasis before an adequate trial of opiate antagonist therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692070     DOI: 10.1097/00042737-200111000-00022

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  12 in total

Review 1.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

2.  Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.

Authors:  Cynthia Levy; Keith D. Lindor
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

3.  Liver Transplantation for Cholestatic Liver Disease.

Authors:  James Neuberger
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

Review 4.  New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma.

Authors:  Hui Wang; Gil Yosipovitch
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

5.  Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease.

Authors:  Wonngarm Kittanamongkolchai; Ziad M El-Zoghby; J Eileen Hay; Russell H Wiesner; Patrick S Kamath; Nicholas F LaRusso; Kymberly D Watt; Carl H Cramer; Nelson Leung
Journal:  Hepatol Int       Date:  2016-12-08       Impact factor: 6.047

Review 6.  Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.

Authors:  Ashley Vander Does; Cynthia Levy; Gil Yosipovitch
Journal:  Am J Clin Dermatol       Date:  2022-07-28       Impact factor: 6.233

Review 7.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Rising plasma nociceptin level during development of HCC: a case report.

Authors:  Andrea Horvath; Aniko Folhoffer; Peter Laszlo Lakatos; Judit Halosz; Gyorgy Illyes; Zsuzsa Schaff; Monika Beatrix Hantos; Kornelia Tekes; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

Review 9.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

10.  BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.

Authors:  Vinod S Hegade; Stuart F W Kendrick; Robert L Dobbins; Sam R Miller; Duncan Richards; James Storey; George Dukes; Kim Gilchrist; Susan Vallow; Graeme J Alexander; Margaret Corrigan; Gideon M Hirschfield; David E J Jones
Journal:  BMC Gastroenterol       Date:  2016-07-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.